Patent directory · USPTO A61K / A61P
Patents matching “ADC THERAPEUTICS SA”
22 pharma patents match "ADC THERAPEUTICS SA" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 22 pharmaceutical patents matching "ADC THERAPEUTICS SA" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11976122
Anti-IL13Rα2 antibodies
granted -
US 11938192
Dosage regimes for the administration of an anti-CD19 ADC
granted -
US 11813335
Pyrrolobenzodiazepine-antibody conjugates
granted -
US 11702473
Site-specific antibody-drug conjugates
granted -
US 11690918
Pyrrolobenzodiazepine-anti-CD22 antibody conjugates
granted -
US 11596696
Combination therapy with an anti-CD25 antibody-drug conjugate
granted -
US 11426467
Dosage regimes for the administration of an anti-CD25 ADC
granted -
US 11384098
Pyrrolobenzodiazepine-antibody conjugates
granted -
US 11318211
Dosage regimes for the administration of an anti-CD19 ADC
granted -
US 11160872
Pyrrolobenzodiazepine-antibody conjugates
granted -
US 11084872
Method for treating breast cancer
granted -
US 10799596
Pyrrolobenzodiazepine-antibody conjugates
granted -
US 10780096
Pyrrolobenzodiazepine-antibody conjugates
granted -
US 10722594
Pyrrolobenzodiazepine-anti-CD22 antibody conjugates
granted -
US 10597450
Antibodies against kidney associated antigen 1 and antigen binding fragments thereof
granted -
US 10544223
Combination therapy with an anti-axl antibody-drug conjugate
granted -
US 10017580
Humanized anti-Tn-MUC1 antibodies and their conjugates
granted -
US 9931415
Pyrrolobenzodiazepine-antibody conjugates
granted -
US 9931414
Pyrrolobenzodiazepine-antibody conjugates
granted -
US 9919056
Pyrrolobenzodiazepine-anti-CD22 antibody conjugates
granted -
US 9855291
Anti-kidney associated antigen 1 (KAAG1) antibodies
granted -
US 9828426
Antibodies against kidney associated antigen 1 and antigen binding fragments thereof
granted